Vasculitis Trial, Recruiting (NCT07278609)

Vasculitis Trial, Recruiting NCT07278609 Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre Condition: Vasculitis

Printed from Voxsanity (voxsanity.com.au) — NCT07278609 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Vasculitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 60 years of age or older
You are currently being seen by a rheumatologist at the MUHC (McGill University Health Centre) for a joint or immune system condition — such as rheumatoid arthritis, psoriatic arthritis, lupus, scleroderma, gout, osteoarthritis, or a similar condition
You are currently taking 5 or more regular medications, and at least one of those medications is considered potentially unsuitable for older adults (confirm with trial site)
You are expected to continue having regular rheumatology check-up appointments roughly every 3 to 9 months

Who may not be able to join:

You are not able to give your own informed consent to participate in the study
You have a serious illness that is immediately life-threatening, or your doctors estimate you have less than 12 months to live

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Arielle Mendel, MD MSc, RI-MUHC/MUHC

Phone: 5149341934

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07278609

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase: Not Applicable

Status: Recruiting

Condition: Vasculitis

Trial contact: 5149341934

More information: https://clinicaltrials.gov/study/NCT07278609

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 60 years of age or older
You are currently being seen by a rheumatologist at the MUHC (McGill University Health Centre) for a joint or immune system condition — such as rheumatoid arthritis, psoriatic arthritis, lupus, scleroderma, gout, osteoarthritis, or a similar condition
You are currently taking 5 or more regular medications, and at least one of those medications is considered potentially unsuitable for older adults (confirm with trial site)
You are expected to continue having regular rheumatology check-up appointments roughly every 3 to 9 months

Who may not be able to join:

You are not able to give your own informed consent to participate in the study
You have a serious illness that is immediately life-threatening, or your doctors estimate you have less than 12 months to live

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Registry

ClinicalTrials.gov

Start date

29 October 2025

Est. completion

31 March 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

PIM deprescribing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov